|
Çѱ¹MSD À¯ÇÑȸ»ç |
CRA 6¸í ä¿ë
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
10.04 |
|
|
¸®ÄÚ¸®ÁÖ½Äȸ»ç |
ÈÀåÇ°, ÀǾà¿ÜÇ°(º¸Å彺,ÇÊ·¯) ¿µ¾÷»ç¿ø ¸ðÁýÇÕ´Ï´Ù.
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°Ç°º¸Á¶½ÄÇ°/ÈÀåÇ°¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
10.16 |
|
|
(ÁÖ)ÄÚ¸®¾Æ¹ÙÀÌ¿À¹Í½º |
¿µ¾÷Áö¿ø¹× ±â¼ú¿µ¾÷Áö¿ø
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
½ÅÀÔ |
ä¿ë½Ã |
05.11 |
|
|
Çѱ¹MSD À¯ÇÑȸ»ç |
Oncology Pricing&Reimburse specialist¸ðÁý
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
3³â¡è |
ä¿ë½Ã |
11.15 |
|
|
(ÁÖ)Çʷνýº |
±¹³»¿µ¾÷ºÎ º´¿øÆÀ Á¤±ÔÁ÷ ¸ðÁý °ø°í(½ÅÀÔ, °æ·Â)
°æ±â ¼º³²½Ã ºÐ´ç±¸ | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
09.27 |
|
|
¾Æº§¸®³ë |
¾Æº§¸®³ë Çѱ¹¹ýÀÎ - GA ( Ãѹ«) ´ã´çÀÚ¸¦ ä¿ëÇÕ´Ï´Ù.
¼¿ï °³²±¸ | Çз¹«°ü |
»ç¹«/Ãѹ«/¹ý¹«/ƯÇã |
°æ·Â¹«°ü |
ä¿ë½Ã |
05.24 |
|
|
¶ó¿ÂÄ¿¸Ó½º ÁÖ½Äȸ»ç |
ETC/OTC ÀǾàÇ° ¹× °Ç±â½Ä ¿µ¾÷/ ¸¶ÄÉÆÃ
¼¿ï °³²±¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
ä¿ë½Ã |
10.24 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Head of Medical - Sanofi Pasteur Korea
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
5³â¡è |
ä¿ë½Ã |
06.16 |
|
|
Çѱ¹Organon |
Çѱ¹Organon-Market Access Specialist 1¸í ¸ðÁý
¼¿ï Á¾·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
12.04 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] In-house CRA ä¿ë°ø°í
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
°æ·Â¹«°ü |
ä¿ë½Ã |
02.03 |
|
|
(ÁÖ)¿¡½º¿¤¸ÞµðÄɾî |
Çؿܹ«¿ª °æ·ÂÁ÷ ä¿ë
¼¿ï µ¿ÀÛ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
1³â¡è |
ä¿ë½Ã |
08.22 |
|
|
ÀºÁØÆʹÙÀÌ¿À |
°æ·ÂÁ÷ ¿µ¾÷»ç¿ø
°æ±â ÀüÁö¿ª | Çз¹«°ü |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
3³â¡è |
»ó½Ãä¿ë |
12.11 |
|
|
PSI CRO Korea |
[PSI CRO Korea] SSU Associate
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
SSU |
2³â¡è |
ä¿ë½Ã |
05.04 |
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
BDºÎ¼ BD Manager ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
1³â¡è |
ä¿ë½Ã |
08.03 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] °æ·Â Project Managerä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
4³â¡è |
ä¿ë½Ã |
01.28 |
|